Citurgia Biochemicals Limited (BOM:506373)

Citurgia Biochemicals Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Selling, General & Admin	1.77	1.69	1.69	1.62	1.6
Other Operating Expenses	3.4	0.28	0.81	0.48	0.19
Operating Expenses	7.43	4.23	4.76	4.36	4.04
Operating Income	-7.43	-4.23	-4.76	-4.36	-4.04
Interest Expense	-	-0	-0	-0	-0
Pretax Income	-7.43	-4.23	-4.76	-4.36	-4.04
Net Income	-7.43	-4.23	-4.76	-4.36	-4.04
Net Income to Common	-7.43	-4.23	-4.76	-4.36	-4.04
Shares Outstanding (Basic)	-	132	132	132	132
Shares Outstanding (Diluted)	-	132	132	132	132
EPS (Basic)	-	-0.03	-0.04	-0.03	-0.03
EPS (Diluted)	-	-0.03	-0.04	-0.03	-0.03
EBITDA	-5.17	-1.97	-2.5	-2.1	-1.78
D&A For EBITDA	2.26	2.26	2.26	2.26	2.26
EBIT	-7.43	-4.23	-4.76	-4.36	-4.04
Advertising Expenses	-	-	-	-	0.01

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 11, 2026

Data Sources Report a data error